• English
  • Vacancies
  • Client login
  • Bezuidenhoutseweg 101, The Hague
  • Avenue des Arts 39, Brussels
  • Nederlands Nederlands Dutch nl
  • English English English en
Public Matters
  • Home
  • Services
  • Sectors
  • People
  • About us
  • News
  • Vacancies
  • Contact
  • Client login
  • +31 (0) 70 304 6499
  • Direct mail
  • English
  • Menu
News

Policy developments in the Dutch healthcare sector due to COVID-19

02-04-2020
  • Share on Facebook
  • Share on Twitter
  • Share on Linkedin
  • Share by Mail

25 March 2020
Like in other countries, the coronavirus has a significant impact on the Dutch health care sector. Although the consequences are not only very clear yet, policies are being developed to support hospitals, companies and employees within the healthcare sector as much as possible. This blog provides an overview of some of these policy developments.

Shortages of (medical) devices

There is a shortage of medical devices such as test kits, disinfectants, respiratory equipment and personal protective equipment. To address the shortages, (academic) hospitals have set up a joint procurement agency, and the Ministry of Health has announced the purchase of additional respiratory equipment from abroad and other sectors, such as military institutions, veterinary practices and private clinics. In addition, the government focuses on setting up its own production capacity for medical equipment, in cooperation with companies and technical universities.

During the first parliamentary debate on the coronavirus crisis, GroenLinks (Greens, an opposition party), managed to receive a commitment by the minister of Medical Care, for that Ministry of Health to start a claim procedure with regards to personal protective equipment. However, After the debate, the government announced that this commitment was reconsidered, since the announcement had already deterred multiple sellers and foreign suppliers from supplying in the Netherlands.

IC capacity and medical staff

The capacity of IC departments is being expanded by various measures to prevent excessive overload. The total number of IC places will be increased from 1150 to 2400 beds, and also elective care (e.g. planned surgical procedures) is scaled down to free up beds for Corona patients. In addition to these capacity expansion, there is a centrally coordinated redistribution of patients across the Netherlands, other locations will be set up where artificial respiration can take place, and medical staff will be deployed at the IC department.

Due to the huge demand on healthcare staff, and the fact that they also have to comply with the regulations to stay at home – for example when having the flu, staff shortage is becoming unavoidable. Former care workers are therefore (temporarily) deployed and retrained if necessary. In order to speed up this process, legislation with regards to the BIG-register, amongst other things, has been temporarily made less strict.

In addition, the Ministry of Health has immediately freed up money for extra digital applications to enable support and care from a distance. A special emergency scheme has been set up within the “Stimulating regulation E-health Home” (SET): SET Covid-19. This allows the continuance of the care of vulnerable elderly people that live at home or people with a chronic illness or disability.

Medicines & vaccines

Several measurements have been announced to deal with medicine shortages caused by COVID-19. For example, it has been announced that maximum prices will be abandoned of medicines that have relatively low prices or a low turnover in the Netherlands. The maximum price for individual products outside this category can also be released if there is a threat of shortages. The final criteria are expected to be published at the end of this week. According to several sources, it seems that the Ministry of Health is not intended to postpone the planned revision of the maximum prices for medicines as of 1 April, as stated by various sector associations in a letter to the Ministry.

In addition, companies and researchers in the Netherlands are working hard on the development of a vaccine against COVID-19. Because Dutch legislation and regulations regarding the testing and assessing of new vaccines are much stricter than in other European countries, companies move the follow-up processes in other countries. To prevent this from happening in the future, the ask of the healthcare sector for a reassessment of the Dutch processes for vaccines is becoming stronger.

Policies are being developed to support hospitals, companies and employees within the healthcare sector as much as possible.

Read more:

New talents join Team Public Matters
07 Apr 2022
Uitgelicht
News
EU reaches agreement on Digital Markets Act (DMA)
25 Mar 2022
News
Saying goodbye to gas – is the war in Ukraine accelerating Europe’s energy transition?
18 Mar 2022
Opinion
UPDATE DUTCH POLITICS: local parties big winners of municipal elections
17 Mar 2022
News
Looking back: a dialogue on lobbying in the Slovenian Parliament
03 Mar 2022
Opinion

  • Kom jij ons team versterken als Trainee? Solliciteren kan tot maandag 23 mei! #werkenbijpm https://t.co/9HmjkBtH37

    2022-05-19 15:08:28




  • In een nieuwe aflevering van onze #pmpodcast ‘In de Lobby’ gaat @EULobby in gesprek met @wytzerusschen, voormalig toplobbyist in #Brussel. Luisteren! https://t.co/NtaxY3ke4P #IndeLobby https://t.co/hBhbWJxygj

    2022-05-19 08:50:17




  • De #Troonrede wordt dit jaar uitgesproken in de Koninklijke Schouwburg van Den Haag. De Ridderzaal, waar traditioneel de Troonrede wordt uitgesproken, is de komende jaren niet beschikbaar vanwege de renovatie van het Binnenhof https://t.co/Hmp24sIysd #Prinsjesdag

    2022-05-18 13:44:26




  • Daarnaast zal prinses Amalia dit jaar voor het eerst op #Prinsjesdag aanwezig zijn https://t.co/0qU1xKVS4K https://t.co/TMkzAMLpjQ

    2022-05-18 13:47:40




  • De Algemene Rekenkamer maakt zich ernstig zorgen over het beheer van de overheidsfinanciën: van bijna 5 procent van alle verplichtingen die de Rijksoverheid in 2021 vastlegde, staat niet vast of ze rechtmatig zijn https://t.co/SNoCShy5D2 #Verantwoordingsdag #gehaktdag

    2022-05-18 11:09:32




  • Vandaag is het de derde woensdag van mei: traditioneel #Verantwoordingsdag in de Tweede Kamer. Op deze dag legt het kabinet verantwoording af over het voorgaande jaar https://t.co/6sz5PNxNnn

    2022-05-18 09:07:32




  • De leden van @GroenLinks mogen zich uitspreken over de vraag of de partij in de Eerste Kamer na de verkiezingen van volgend jaar een gezamenlijke fractie moet gaan vormen met de @PvdA. Ook de PvdA zal zich in juni uitspreken over verdere samenwerking https://t.co/mJOa0QyHpc

    2022-05-17 15:55:13




  • Public Matters bestaat 20 jaar, en vierde dit in het Haagse @nieuwspoort ! Aan de hand van ons #lustrumboek spraken we in een interactieve paneldiscussie over de trends in de relatie tussen belangenbehartigers en beleidsmakers #lustrum #publicaffairs
    https://t.co/Lr8tJrf2Kl

    2022-05-13 11:59:22




  • Grote dank aan @thomasvanzijl voor het modereren, en aan onze panelleden @caelestabraun, @erikziengs, Moni Wiltenburg en @pcouwenbergh voor jullie bijdrage aan deze dag! https://t.co/fijP4z9Dzm

    2022-05-13 11:59:24




  • Vandaag bood collega Peter van Keulen het #lustrumboek van Public Matters aan de minister van VWS aan. Morgen hierover een gesprek tijdens een bijeenkomst in Perscentrum #Nieuwspoort. https://t.co/ByUnkakqLG

    2022-05-11 18:38:52




Public Matters is a leading public affairs & lobby consultancy in the Netherlands and Brussels supporting organisations that seek to influence policy and engage in strategic communications.

Office The Hague
Bezuidenhoutseweg 101
2594 AC Den Haag
+31 (0)70 3046 499

Office Brussels
Avenue des Arts 39
B-1040 Brussel
+ 32 (0)2 502 77 71

Social media

  • Twitter
  • LinkedIn
  • Instagram

info@publicmatters.nl

” Tech against Corona” Initiative of Dutch tech companies offers... Public affairs during the coronacrisis: government relations are crucial
Scroll to top